Institutional Ownership
Fate Therapeutics Inc
CUSIP 31189P102COMFATEQ1 2026
13D / 13G Filings
44
Schedule 13D/13G on record
Beneficial Filers
16
Distinct reporting persons
Largest Stake
14.9%
Max % of class reported
Institutional Holders
151
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
44 filings · latest Aug 14, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Aug 14, 2025 | Schonfeld Strategic Advisors LLC | 13G/A | 0.8% | 937.5K | SEC |
| 2 | Aug 14, 2025 | The Goldman Sachs Group, Inc. | 13G/A | 11.0% | 2.27M | SEC |
| 3 | Jul 29, 2025 | The Vanguard Group | 13G/A | 7.6% | 8.77M | SEC |
| 4 | Jul 3, 2025 | Redmile Group, LLC | 13D/A | 14.9% | — | SEC |
| 5 | May 15, 2025 | Schonfeld Strategic Advisors LLC | 13G | 6.8% | 7.79M | SEC |
| 6 | May 9, 2025 | The Goldman Sachs Group, Inc. | 13G | 11.0% | 8.49M | SEC |
| 7 | Apr 23, 2025 | Blackrock, Inc. | 13G/A | 6.9% | 7.85M | SEC |
| 8 | Dec 26, 2024 | Redmile Group, LLC | 13D/A | 14.9% | — | SEC |
| 9 | Nov 14, 2024 | Point72 Asset Management, L.P. | 13G/A | — | — | SEC |
| 10 | Nov 8, 2024 | Blackrock, Inc. | 13G/A | 9.2% | 10.47M | SEC |
34 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Fate Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Redmile Group, LLC | 12.87M | $15.45M |
| 2 | Blackrock, Inc. | 10.07M | $12.08M |
| 3 | Two Sigma Investments, LP | 3.47M | $4.16M |
| 4 | Johnson & Johnson | 3.38M | $4.05M |
| 5 | Aqr Capital Management LLC | 3.00M | $3.60M |
| 6 | Renaissance Technologies LLC | 2.97M | $3.57M |
| 7 | Geode Capital Management, LLC | 2.59M | $3.11M |
| 8 | State Street Corp | 2.26M | $2.72M |
| 9 | Ubs Group AG | 1.82M | $2.19M |
| 10 | Goldman Sachs Group Inc | 1.33M | $1.59M |